Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “Radiation Protection”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,099 records · Page 61
All sourcesNASA NTRSDOE OSTI
DOE OSTI2015

Analysis of activated air following high yield shots in the NIF

During the ignition experimental campaign, the National Ignition Facility (NIF) is expected to perform shots with varying fusion yield (up to 20 MJ or 7.1 x 10 18 neutrons per shot) and a maximum annual yield of 1200 MJ. A detailed MCNP model of the Target Bay (TB) and the two switchyards (SY) has been developed to estimate the post-shot radiation environment inside the facility. During D-T shots, a pulse of 14.1 MeV neutrons streaming outside the Target Chamber (TC) will activate the air present inside the TB and the argon gas inside the laser tubes. Smaller levels of activity are also generated in the SY air and in the argon portion of the SY laser beam path. The activated TB air will be mixed with fresh air from the Operations Support Building (OSB) before release through the stack. Flow of activated air from the Target Bay is controlled by the heating, ventilating, and air conditioning (HVAC) system. 16 N (T 1/2 = 7.13 s) dominates the radiation levels during the first minute following the shot. It is expected that 16 N will decay away during the confinement time before releasing the TB air through the stack. The other major contributors are 13 N (T 1/2 = 9.97 min) and 41 Ar (T 1/2 = 1.83 h). In general a low dose rate of < 1 μSv/h is expected near the stack during the first few hours following a 20 MJ shot. Here, the amount of activated Target Bay air released through the stack is very small and does not pose significant hazard to personnel or the environment. In the mean time, due to a very small leakage rate out of the laser tubes, the activated argon gas decays within the tubes and any resulting release to the environment is insignificant.

61 RADIATION PROTECTION AND DOSIMETRY↗
DOE OSTI2014

Final Report: Part 1. In-Place Filter Testing Instrument for Nuclear Material Containers. Part 2. Canister Filter Test Standards for Aerosol Capture Rates.

A portable instrument has been developed to assess the functionality of filter sand o-rings on nuclear material storage canisters, without requiring removal of the canister lid. Additionally, a set of fifteen filter standards were procured for verifying aerosol leakage and pressure drop measurements in the Los Alamos Filter Test System. The US Department of Energy uses several thousand canisters for storing nuclear material in different chemical and physical forms. Specialized filters are installed into canister lids to allow gases to escape, and to maintain an internal ambient pressure while containing radioactive contaminants. Diagnosing the condition of container filters and canister integrity is important to ensure worker and public safety and for determining the handling requirements of legacy apparatus. This report describes the In-Place-Filter-Tester, the Instrument Development Plan and the Instrument Operating Method that were developed at the Los Alamos National Laboratory to determine the “as found” condition of unopened storage canisters. The Instrument Operating Method provides instructions for future evaluations of as-found canisters packaged with nuclear material. Customized stainless steel canister interfaces were developed for pressure-port access and to apply a suction clamping force for the interface. These are compatible with selected Hagan-style and SAVY-4000 storage canisters that were purchased from NFT (Nuclear Filter Technology, Golden, CO). Two instruments were developed for this effort: an initial Los Alamos POC (Proof-of-Concept) unit and the final Los Alamos IPFT system. The Los Alamos POC was used to create the Instrument Development Plan: (1) to determine the air flow and pressure characteristics associated with canister filter clogging, and (2) to test simulated configurations that mimicked canister leakage paths. The canister leakage scenarios included quantifying: (A) air leakage due to foreign material (i.e. dust and hair) fouling of o-rings, (B) leakage through simulated cracks in o-rings, and (C) air leakage due to inadequately tightened canister lids. The Los Alamos POC instrument determined pertinent air flow and pressure quantities, and this knowledge was used to specify a customized Isaac® (Z axis, Salt Lake City, UT) leak test module. The final Los Alamos IPFT (incorporating the Isaac® leak test module) was used to repeat the tests in the Instrument Development Plan (with simulated filter clogging tests and canister leak pathway tests). The Los Alamos IPFT instrument is capable of determining filter clogging and leak rate conditions, without requiring removal of the container lid. The IPFT measures pressure decay rate from 1.7E-03 in WC/sec to 1.7E-01 in WC/sec. On the same unit scale, helium leak testing of canisters has a range from 5.7E-07 in WC/sec to 1.9E-03 in WC/sec. For a 5-quart storage canister, the IPFT measures equivalent leak flow rates from 0.03 to 3.0 cc/sec. The IPFT does not provide the same sensitivity as helium leak testing, but is able to gauge the assembled condition of as-found and in-situ canisters.

61 RADIATION PROTECTION AND DOSIMETRY↗
DOE OSTI2018

Radioactive aerosols training

An introduction to radioactive aerosols will be presented in this class. There will be a specific focus on transuranic materials, typical to those used in operations at Los Alamos. The uptake of radioactive aerosols is affected by the physical characteristics of the airborne material, the behavior of the aerosol in air (or gas), and the interaction of the material with the worker. Aerosol behavior in the radiological workplace will influence filtration, release control, and dose considerations. This course will review the basics of aerosol technology, distinguishing between the classical (Newtonian) and molecular (quantized) regimes. Particles from about 1 to 10 microns (diameter) are described by classical physics, but particles from about 0.01 to 0.3 microns must be understood through modern molecular theory (i.e. Einstein, 1905). The class will discuss relevant LANL accidents that involved aerosol releases from the years 1971, 1994, 2000, 2003 and 2005.

61 RADIATION PROTECTION AND DOSIMETRY↗
DOE OSTI2020

General Employee Radiological Refresher Training (Self-Study 47968)

This General Employee Radiological Training (GERT) course is designed to refresh knowledge of basic radiological principles and terms, the risks of exposure to ionizing radiation, LANL radiological hazards and postings, ALARA tools, emergency response responsibilities, and how to obtain personal radiological dose records.

61 RADIATION PROTECTION AND DOSIMETRY↗
DOE OSTI2022

RCT Continuing Training: Item Removal

Welcome to RCT Continuing Training. This quarter's topic will review the fundamental elements of removing items from controlled areas to include: evaluation if an item may be released and the actions necessary to perform a release from a controlled area. To complete this training, you will be required to view the online presentation and independently complete its associated quiz.

61 RADIATION PROTECTION AND DOSIMETRY↗
DOE OSTI2014

Comparing the Predicted Neutron Yields and Radioactivities of Two Accelerators in Taiwan: 235-MeV Proton Cyclotron and 3-GeV Electron Synchrotron - Paper 27

Two major accelerator facilities in Taiwan are about to open. The first proton treatment center equipped with a 235 MeV proton cyclotron and four gantry rooms in Linkou Chang Gung Memorial Hospital is currently under beam commissioning and clinical trials are expected to start soon. In addition, the second light source facility, named Taiwan Photon Source (TPS), in National Synchrotron Radiation Research Center is now approaching its final assembly and will be ready for beam commissioning in this year. These two facilities mark significant milestones in accelerator development and application of Taiwan. Operation of these accelerators could potentially produce intense secondary neutrons and serious material activation. Both issues are crucial and must be carefully evaluated for the purpose of radiation safety, especially in a densely populated hospital or in a crowded user experimental floor. Monte Carlo simulations with evaluated cross sections or benchmarked nuclear models are considered as the most reliable method for accelerator shielding designs or related analyses. This study predicted and compared the magnitudes of potential neutron production and induced radioactivity due to the operation of these two accelerators. For conservative consideration, the primary particle energy and full beam output were assumed to hit a thick target for maximum radiation production. In order to ensure the quality of predictions, much effort has been devoted to associated benchmark calculations, targeting those bombardment experiments involving with the same particle types and similar beam energies and targets. (authors)

43 PARTICLE ACCELERATORS↗
DOE OSTI2013

Decrease the Number of Glovebox Glove Breaches and Failures

Los Alamos National Laboratory (LANL) is committed to the protection of the workers, public, and environment while performing work and uses gloveboxes as engineered controls to protect workers from exposure to hazardous materials while performing plutonium operations. Glovebox gloves are a weak link in the engineered controls and are a major cause of radiation contamination events which can result in potential worker exposure and localized contamination making operational areas off-limits and putting programmatic work on hold. Each day of lost opportunity at Technical Area (TA) 55, Plutonium Facility (PF) 4 is estimated at $1.36 million. Between July 2011 and June 2013, TA-55-PF-4 had 65 glovebox glove breaches and failures with an average of 2.7 per month. The glovebox work follows the five step safety process promoted at LANL with a decision diamond interjected for whether or not a glove breach or failure event occurred in the course of performing glovebox work. In the event that no glove breach or failure is detected, there is an additional decision for whether or not contamination is detected. In the event that contamination is detected, the possibility for a glove breach or failure event is revisited.

61 RADIATION PROTECTION AND DOSIMETRY↗
DOE OSTI2016

MO-DE-BRA-05: EUTEMPE-RX: Combining E-Learning and Face-To-Face Training to Build Expert Knowledge, Skills and Competences for Medical Physicists in Diagnostic and Interventional Radiology

Purpose: In 2013, the EURATOM authorities of the European Commission decided to support the Horizon2020 project submission ‘EUTEMPE-RX’ that aimed for a new set of course modules to train medical physicists in diagnostic and interventional radiology to expert level with small group deep learning. Each module would consist of 2 phases: an e-learning and a face-to-face phase, each phase requiring typically 40h of participant time. Methods: The European Federation (EFOMP) and 13 European partners, all of them selected for their excellent scientific and/or educational skills, led the 12 course modules. A quality manual ensured the quality of course content and organization. Educational workshops familiarized the teachers with e-learning techniques and methods for assessment. Content was set in accordance with the EC document RP174 that lists learning outcomes in terms of knowledge, skills and competences (KSCs) for different specialties and levels of medical physics. Surveys for stake holder satisfaction were prepared. Results: Today the course modules are being realized. The modules cover most of the KSCs in RP174 document. Teachers have challenged the participants with unique tasks: case studies in medical physics leadership, Monte Carlo simulation of a complete x-ray imaging chain, development of a task specific QA protocol, compilation of optimization plans, simulation tasks with anthropomorphic breast models, etc. Participants undertook practical sessions in modern hospitals and visited a synchrotron facility, a calibration lab, screening organizations, etc. Feedback form quality surveys was very positive and constructive. A sustainability plan has been worked out. Conclusion: The modules have enabled the participants to develop their KSCs and cope with challenges in medical physics. The sustainability plan will be implemented to continue the unique combined e-learning and face to face training at high level training in diagnostic and interventional radiology also beyond Europe. The EUTEMPE-RX project is funded by the Horizon2020 - EURATOM program of the European Commission.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2018

Gamma and Beta Absorbed Dose Conversion Coefficients in the Range from 10 keV to 10 MeV for Accidental Exposures From Point Sources Placed in Clothing in Proximity to the Body [Gamma and Beta Absorbed Dose Conversion Coefficients in the Range from 10 keV to 10 MeV for Accidental Exposures From Point Sources Placed in Clothing in Close Vicinity to the Body]

Here, retrospective dose assessment following acute radiation exposures during radiological incidents can be difficult and inaccurate due to the large uncertainties associated with dose estimation. However, rapid and accurate dose assessment is critical following an incident, such that appropriate treatment can be provided to the patient as early as possible. Incident Dose assessment relies heavily on biological dosimetry with corresponding large uncertainties for inhomogeneous exposures, resulting from the estimates of whole-body doses, while the assessment of absorbed doses to individual tissues might actually be more appropriate for acute radiation exposures.

61 RADIATION PROTECTION AND DOSIMETRY↗
DOE OSTI2020

Chelation Modeling: The Use of Ad Hoc Models and Approaches to Overcome a Dose Assessment Challenge

Here, chelating agents are administered to treat significant intakes of radioactive elements such as plutonium, americium, and curium. These drugs may be used as a medical countermeasure after radiological accidents and terrorist acts. The administration of a chelating agent, such as Ca-DTPA or Zn-DTPA, affects the actinide's normal biokinetics. It enhances the actinide's rate of excretion, posing a dose assessment challenge. Thus, the standard biokinetic models cannot be directly applied to the chelation-affected bioassay data in order to assess the radiation dose. The present study reviews the scientific literature, from the early 1970s until the present, on the different studies that focused on developing new chelation models and/or modeling of bioassay data affected by chelation treatment. Although scientific progress has been achieved, there is currently no consensus chelation model available, even after almost 50 y of research. This review acknowledges the efforts made by different research groups, highlighting the different methodology used in some of these studies. Finally, this study puts into perspective where we were, where we are, and where we are heading in regards to chelation modeling.

61 RADIATION PROTECTION AND DOSIMETRY↗
DOE OSTI2022

Applying ALARA Principles in the Design of New Radiological Facilities

The application of ALARA (As Low As Reasonably Achievable) principles to the design of new radiological facilities at Argonne National Laboratory provides a consistent radiation safety basis for future facility operations. The Department of Energy Rule 10 CFR 835 specifies design objectives to be adopted during the design of new facilities for controlling personal radiation exposure. One is to keep exposure levels below 20% of the applicable standards in 10 CFR 835.202. For a radiation worker 20% of the standard corresponds to 5 µSv hr -1 for a 2,000 hour work year. For a member of the public the DOE design objective corresponds to 0.2 mSv in a calendar year. For a new facility worst case radionuclides and their source strengths are chosen. Local shielding is specified to reduce exposure rates to less than 50 µSv hr -1 at 30 cm from the shielding. The current version MCNP6 of the Los Alamos radiation shielding computer program MCNP is then used to calculate the exposure rates elsewhere. Design modifications are made to meet the criteria. The calculations and resulting facility design modifications are discussed for two new radiological facilities.

61 RADIATION PROTECTION AND DOSIMETRY↗
DOE OSTI2014

TU-A-17A-01: Memorial to Benjamin M. Galkin - Memorial Lecture

This past year Medical Physics lost one of its active members, Benjamin M. Galkin. Ben Galkin was a Past-Treasurer of the AAPM. During his leadership role he played an important part in Securing membership, for the AAPM, in the American Institute of physics. As Treasurer he was also a prime mover in starting the journal, Medical Physics, and served as its business manager in the formative years.Ben Galkin received his Masters Degree at Columbia University in New York, under the mentorship of Dr. Edith Quimby, one of the pioneer Hospital Radiation Physicists in the country. He started his professional career at Jefferson Hospital in Philadelphia, joining Robert Gorson, and remained there until retirement. He served as the institution’s Radiation Safety Officer throughout his career. His research interest was Breast Imaging. He held joint faculty appointments in the Department of Radiology and the Department of Radiation Therapy and Nuclear Medicine, rising up to the rank of Full professor. He was a well respected teacher for the residents in Radiology.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2015

SU-E-E-03: Shared Space Fosters Didactic and Professional Learning Across Professions for Medical and Physics Residents

Purpose: Medical Physicists and Radiation Oncologists are two professions who should be working as a team for optimal patient care, yet lack of mutual understanding about each others respective role and work environment creates barriers To improve collaboration and learning, we designed a shared didactic and work space for physics and radiation oncology residents to maximize interaction throughout their professional training. Methods: Physician and Physics residents are required to take the same didactic classes, including journal clubs and respective seminars. The residents also share an office environment among the seven physician and two physic residents. Results: By maximizing didactic overlap and sharing office space, the two resident groups have developed a close professional relationship and supportive work environment. Several joint research projects have been initiated by the residents. Awareness of physics tasks in the clinic has led to a request by the physician residents to change physics didactics, converting the physics short course into a lab-oriented course for the medical residents which is in part taught by the physics residents. The physics seminar is given by both residency groups; increased motivation and interest in learning about physics has led to several medical resident-initiated topic selections which generated lively discussion. The physics long course has changed toward including more discussion among residents to delve deeper into topics and study beyond what passing the boards would require. A supportive work environment has developed, embedding the two physics residents into a larger residents group, allowing them to find mentor and peers more easily. Conclusion: By creating a shared work and didactic environment, physician and physics residents have improved their understanding of respective professional practice. Resident-initiated changes in didactic practice have led to improved learning and joint research. A strong social support system has developed, embedding physics residents into a larger peer group.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2016

SU-F-P-13: NRG Oncology Medical Physics Manpower Survey Quantifying Support Demands for Multi Institutional Clinical Trials

Purpose: A survey was taken by NRG Oncology to assess Full Time Equivalent (FTE) contributions to multi institutional clinical trials by medical physicists.No current quantification of physicists’ efforts in FTE units associated with clinical trials is available. The complexity of multi-institutional trials increases with new technologies and techniques. Proper staffing may directly impact the quality of trial data and outcomes. The demands on physics time supporting clinical trials needs to be assessed. Methods: The NRG Oncology Medical Physicist Subcommittee created a sixteen question survey to obtain this FTE data. IROC Houston distributed the survey to their list of 1802 contact physicists. Results: After three weeks, 363 responded (20.1% response). 187 (51.5%) institutions reporting external beam participation were processed. There was a wide range in number of protocols active and supported at each institution. Of the 187 clinics, 134 (71.7%) participate in 0 to 10 trials, 28 (15%) in 11 to 20 trials, 10 (5.3%) in 21 to 30 trials, 9 (4.8%) had 40 to 75 trials. On average, physicist spent 2.7 hours (SD: 6.0) per week supervising or interacting with clinical trial staff. 1.25 hours (SD: 3.37), 1.83 hours (SD: 4.13), and 0.64 hours(SD: 1.13) per week were spent on patient simulation, reviewing treatment plans, and maintaining a DICOM server, respectively. For all protocol credentialing activities, physicist spent an average of 37.05 hours (SD: 96.94) yearly. To support dosimetrists, clinicians, and therapists, physicist spend on average 2.07 hours (SD: 3.52) per week just reading protocols. Physicist attended clinical trial meetings for on average 1.13 hours (SD: 1.85) per month. Conclusion: Responding physicists spend a nontrivial amount of time: 8.8 hours per week (0.22 FTE) supporting, on average, 9 active multi-institutional clinical trials.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2016

MO-A-BRC-02: TG167 Report - Detailed Description

Although a multicenter, Phase III, prospective, randomized trial is the gold standard for evidence-based medicine, it is rarely used to evaluate innovative radiotherapy devices because of many practical and ethical reasons. It is usually sufficient to compare the dose distributions and dose rates for determining equivalence of the innovative device to an existing one. Thus, quantitative evaluation of the dosimetric characteristics of an innovative brachytherapy device or application is a critical part in which physicists are actively involved. The physicist’s role, along with physician colleagues, in this process is highlighted for innovative products or applications and includes evaluation of 1) dosimetric considerations for clinical implementation (including calibrations, dose calculations, and radiobiological aspects) to comply with existing societal dosimetric prerequisites for sources in routine clinical use, 2) risks and benefits from regulatory and safety perspectives, and 3) resource assessment and preparedness. Further, calibration methods should be traceable to a primary standards dosimetry laboratory such as NIST in the U.S. or to other primary standards dosimetry laboratory located elsewhere. Clinical users should follow standards as approved by their country’s regulatory agencies that approved such a brachytherapy device. Integration of this system into the medical source calibration infrastructure of secondary standard dosimetry laboratories such as the ADCLs is encouraged before a source is introduced into widespread routine clinical use. The AAPM and GEC-ESTRO have developed guidelines for the safe and consistent application of brachytherapy using innovative brachytherapy devices and applications. The current report covers regulatory approvals, calibration, dose calculations, radiobiological issues, and overall safety concerns that should be addressed during the commissioning stage preceding clinical use. These guidelines are based on review of requirements of the U.S. NRC, FDA, Department of Transportation, International Electrotechnical Commission Medical Electrical Equipment Standard 60601, European Commission for CE Marking, and institutional review boards and radiation safety committees. Learning Objectives: Understand the necessary dosimetric considerations for clinical implementation (including calibrations, dose calculations, and radiobiological aspects) to comply with existing societal dosimetric prerequisites for sources in routine clinical use. Evaluate risks and benefits from regulatory and safety perspectives. Identify necessary resources and create a plan for clinical introduction of innovative brachytherapy device or applications. Consultant for Theragenics Corp.; R. Nath, Consultant to Theragenics Corp.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2016

MO-A-BRC-00: TG167: Clinical Recommendations for Innovative Brachytherapy Devices and Applicators

Although a multicenter, Phase III, prospective, randomized trial is the gold standard for evidence-based medicine, it is rarely used to evaluate innovative radiotherapy devices because of many practical and ethical reasons. It is usually sufficient to compare the dose distributions and dose rates for determining equivalence of the innovative device to an existing one. Thus, quantitative evaluation of the dosimetric characteristics of an innovative brachytherapy device or application is a critical part in which physicists are actively involved. The physicist’s role, along with physician colleagues, in this process is highlighted for innovative products or applications and includes evaluation of 1) dosimetric considerations for clinical implementation (including calibrations, dose calculations, and radiobiological aspects) to comply with existing societal dosimetric prerequisites for sources in routine clinical use, 2) risks and benefits from regulatory and safety perspectives, and 3) resource assessment and preparedness. Further, calibration methods should be traceable to a primary standards dosimetry laboratory such as NIST in the U.S. or to other primary standards dosimetry laboratory located elsewhere. Clinical users should follow standards as approved by their country’s regulatory agencies that approved such a brachytherapy device. Integration of this system into the medical source calibration infrastructure of secondary standard dosimetry laboratories such as the ADCLs is encouraged before a source is introduced into widespread routine clinical use. The AAPM and GEC-ESTRO have developed guidelines for the safe and consistent application of brachytherapy using innovative brachytherapy devices and applications. The current report covers regulatory approvals, calibration, dose calculations, radiobiological issues, and overall safety concerns that should be addressed during the commissioning stage preceding clinical use. These guidelines are based on review of requirements of the U.S. NRC, FDA, Department of Transportation, International Electrotechnical Commission Medical Electrical Equipment Standard 60601, European Commission for CE Marking, and institutional review boards and radiation safety committees. Learning Objectives: Understand the necessary dosimetric considerations for clinical implementation (including calibrations, dose calculations, and radiobiological aspects) to comply with existing societal dosimetric prerequisites for sources in routine clinical use. Evaluate risks and benefits from regulatory and safety perspectives. Identify necessary resources and create a plan for clinical introduction of innovative brachytherapy device or applications. Consultant for Theragenics Corp.; R. Nath, Consultant to Theragenics Corp.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2016

MO-A-BRC-01: TG167 Report - Introduction

Although a multicenter, Phase III, prospective, randomized trial is the gold standard for evidence-based medicine, it is rarely used to evaluate innovative radiotherapy devices because of many practical and ethical reasons. It is usually sufficient to compare the dose distributions and dose rates for determining equivalence of the innovative device to an existing one. Thus, quantitative evaluation of the dosimetric characteristics of an innovative brachytherapy device or application is a critical part in which physicists are actively involved. The physicist’s role, along with physician colleagues, in this process is highlighted for innovative products or applications and includes evaluation of 1) dosimetric considerations for clinical implementation (including calibrations, dose calculations, and radiobiological aspects) to comply with existing societal dosimetric prerequisites for sources in routine clinical use, 2) risks and benefits from regulatory and safety perspectives, and 3) resource assessment and preparedness. Further, calibration methods should be traceable to a primary standards dosimetry laboratory such as NIST in the U.S. or to other primary standards dosimetry laboratory located elsewhere. Clinical users should follow standards as approved by their country’s regulatory agencies that approved such a brachytherapy device. Integration of this system into the medical source calibration infrastructure of secondary standard dosimetry laboratories such as the ADCLs is encouraged before a source is introduced into widespread routine clinical use. The AAPM and GEC-ESTRO have developed guidelines for the safe and consistent application of brachytherapy using innovative brachytherapy devices and applications. The current report covers regulatory approvals, calibration, dose calculations, radiobiological issues, and overall safety concerns that should be addressed during the commissioning stage preceding clinical use. These guidelines are based on review of requirements of the U.S. NRC, FDA, Department of Transportation, International Electrotechnical Commission Medical Electrical Equipment Standard 60601, European Commission for CE Marking, and institutional review boards and radiation safety committees. Learning Objectives: Understand the necessary dosimetric considerations for clinical implementation (including calibrations, dose calculations, and radiobiological aspects) to comply with existing societal dosimetric prerequisites for sources in routine clinical use. Evaluate risks and benefits from regulatory and safety perspectives. Identify necessary resources and create a plan for clinical introduction of innovative brachytherapy device or applications. Consultant for Theragenics Corp.; R. Nath, Consultant to Theragenics Corp.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2016

MO-DE-202-00: Image-Guided Interventions: Advances in Intraoperative Imaging, Guidance, and An Emerging Role for Medical Physics in Surgery

At least three major trends in surgical intervention have emerged over the last decade: a move toward more minimally invasive (or non-invasive) approach to the surgical target; the development of high-precision treatment delivery techniques; and the increasing role of multi-modality intraoperative imaging in support of such procedures. This symposium includes invited presentations on recent advances in each of these areas and the emerging role for medical physics research in the development and translation of high-precision interventional techniques. The four speakers are: Keyvan Farahani, “Image-guided focused ultrasound surgery and therapy” Jeffrey H. Siewerdsen, “Advances in image registration and reconstruction for image-guided neurosurgery” Tina Kapur, “Image-guided surgery and interventions in the advanced multimodality image-guided operating (AMIGO) suite” Raj Shekhar, “Multimodality image-guided interventions: Multimodality for the rest of us” Learning Objectives: Understand the principles and applications of HIFU in surgical ablation. Learn about recent advances in 3D–2D and 3D deformable image registration in support of surgical safety and precision. Learn about recent advances in model-based 3D image reconstruction in application to intraoperative 3D imaging. Understand the multi-modality imaging technologies and clinical applications investigated in the AMIGO suite. Understand the emerging need and techniques to implement multi-modality image guidance in surgical applications such as neurosurgery, orthopaedic surgery, vascular surgery, and interventional radiology. Research supported by the NIH and Siemens Healthcare.; J. Siewerdsen; Grant Support - National Institutes of Health; Grant Support - Siemens Healthcare; Grant Support - Carestream Health; Advisory Board - Carestream Health; Licensing Agreement - Carestream Health; Licensing Agreement - Elekta Oncology.; T. Kapur, P41EB015898; R. Shekhar, Funding: R42CA137886 and R41CA192504 Disclosure and CoI: IGI Technologies, small-business partner on the grants.

61 RADIATION PROTECTION AND DOSIMETRY↗